Human KRT8(Keratin 8) ELISA Kit
Human Keratin 8 (KRT8) ELISA Kit |
|||
SEC025Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5677.8 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 8 (KRT8) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 8 (KRT8) ELISA Kit |
|||
SEC025Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 572.76 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 8 (KRT8) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 8 (KRT8) ELISA Kit |
|||
SEC025Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 766.8 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 8 (KRT8) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 8 (KRT8) ELISA Kit |
|||
SEC025Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3090.6 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 8 (KRT8) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 8 (KRT8) ELISA Kit |
|||
4-SEC025Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Keratin 8 (KRT8) in samples from Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Keratin 8(KRT8)ELISA Kit |
|||
QY-E02817 | Qayee Biotechnology | 96T | 433.2 EUR |
Cow Keratin 8 (KRT8) ELISA Kit |
|||
abx519984-96tests | Abbexa | 96 tests | 1093.2 EUR |
Mouse Keratin 8 (KRT8) ELISA Kit |
|||
abx519986-96tests | Abbexa | 96 tests | 801.6 EUR |
Rat Keratin 8 (KRT8) ELISA Kit |
|||
abx519987-96tests | Abbexa | 96 tests | 801.6 EUR |
ELISA kit for Human KRT8 (Keratin 8) |
|||
ELK2755 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Keratin 8 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Human Keratin 8 (KRT8) CLIA Kit |
|||
20-abx493390 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody |
|||
20-abx100367 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody |
|||
20-abx100368 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody |
|||
20-abx100369 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody |
|||
20-abx100370 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody |
|||
20-abx113350 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody |
|||
20-abx013127 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody |
|||
abx330408-100ul | Abbexa | 100 ul | 510 EUR |
Keratin 8 (KRT8) Antibody |
|||
20-abx323598 | Abbexa |
|
|
Recombinant Keratin 8 (KRT8) |
|||
4-RPC025Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Keratin 8 expressed in: E.coli |
|||
Recombinant Keratin 8 (KRT8) |
|||
4-RPC025Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Keratin 8 expressed in: E.coli |
|||
Recombinant Keratin 8 (KRT8) |
|||
4-RPC025Ra02 | Cloud-Clone |
|
|
Description: Recombinant Rat Keratin 8 expressed in: E.coli |
|||
Human Keratin 8 (KRT8) Protein |
|||
20-abx067633 | Abbexa |
|
|
Rat Keratin 8 (KRT8) Protein |
|||
20-abx067634 | Abbexa |
|
|
Rat Keratin 8 (KRT8) Protein |
|||
20-abx067635 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody (Biotin) |
|||
20-abx272238 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody (Biotin) |
|||
20-abx273368 | Abbexa |
|
|
Keratin 8 (KRT8) Antibody (FITC) |
|||
20-abx273653 | Abbexa |
|
|
Keratin 8 (KRT8) Monoclonal Antibody (Human) |
|||
4-MAC025Hu22 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Keratin 8 (KRT8) |
|||
Human KRT8/ Keratin, type II cytoskeletal 8 ELISA Kit |
|||
E1408Hu | Sunlong | 1 Kit | 685.2 EUR |
Human Keratin, type II cytoskeletal 8, KRT8 ELISA KIT |
|||
ELI-07325h | Lifescience Market | 96 Tests | 988.8 EUR |
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat) |
|||
4-PAC025Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8) |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat) |
|||
4-PAC025Ra01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8) |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat) |
|||
4-PAC025Ra02 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8) |
|||
Keratin 8 (KRT8) Monoclonal Antibody (Human), APC |
|||
4-MAC025Hu22-APC | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Keratin 8 (KRT8). This antibody is labeled with APC. |
|||
Keratin 8 (KRT8) Monoclonal Antibody (Human), Biotinylated |
|||
4-MAC025Hu22-Biotin | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Keratin 8 (KRT8). This antibody is labeled with Biotin. |
|||
Keratin 8 (KRT8) Monoclonal Antibody (Human), Cy3 |
|||
4-MAC025Hu22-Cy3 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Keratin 8 (KRT8). This antibody is labeled with Cy3. |
|||
Keratin 8 (KRT8) Monoclonal Antibody (Human), FITC |
|||
4-MAC025Hu22-FITC | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Keratin 8 (KRT8). This antibody is labeled with FITC. |
|||
Keratin 8 (KRT8) Monoclonal Antibody (Human), HRP |
|||
4-MAC025Hu22-HRP | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Keratin 8 (KRT8). This antibody is labeled with HRP. |
|||
Keratin 8 (KRT8) Monoclonal Antibody (Human), PE |
|||
4-MAC025Hu22-PE | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Keratin 8 (KRT8). This antibody is labeled with PE. |
|||
ELISA kit for Human Keratin, type II cytoskeletal 8 (KRT8) |
|||
KTE61873-48T | Abbkine | 48T | 398.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type II cytoskeletal 8 (KRT8) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Keratin, type II cytoskeletal 8 (KRT8) |
|||
KTE61873-5platesof96wells | Abbkine | 5 plates of 96 wells | 2538 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type II cytoskeletal 8 (KRT8) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Keratin, type II cytoskeletal 8 (KRT8) |
|||
KTE61873-96T | Abbkine | 96T | 646.8 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type II cytoskeletal 8 (KRT8) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Mouse Keratin, type II cytoskeletal 8, Krt8 ELISA KIT |
|||
ELI-07323m | Lifescience Market | 96 Tests | 1038 EUR |
Bovine Keratin, type II cytoskeletal 8, KRT8 ELISA KIT |
|||
ELI-07324b | Lifescience Market | 96 Tests | 1113.6 EUR |
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), APC |
|||
4-PAC025Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with APC. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), Biotinylated |
|||
4-PAC025Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with Biotin. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), Cy3 |
|||
4-PAC025Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with Cy3. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), FITC |
|||
4-PAC025Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with FITC. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), HRP |
|||
4-PAC025Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with HRP. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), PE |
|||
4-PAC025Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with PE. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), APC |
|||
4-PAC025Ra01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with APC. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), Biotinylated |
|||
4-PAC025Ra01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with Biotin. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), Cy3 |
|||
4-PAC025Ra01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with Cy3. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), FITC |
|||
4-PAC025Ra01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with FITC. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), HRP |
|||
4-PAC025Ra01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with HRP. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), PE |
|||
4-PAC025Ra01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with PE. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), APC |
|||
4-PAC025Ra02-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with APC. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), Biotinylated |
|||
4-PAC025Ra02-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with Biotin. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), Cy3 |
|||
4-PAC025Ra02-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with Cy3. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), FITC |
|||
4-PAC025Ra02-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with FITC. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), HRP |
|||
4-PAC025Ra02-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with HRP. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), PE |
|||
4-PAC025Ra02-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with PE. |
|||
Keratin 8 (KRT8) Monoclonal Antibody (Human), APC-Cy7 |
|||
4-MAC025Hu22-APC-Cy7 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Keratin 8 (KRT8). This antibody is labeled with APC-Cy7. |
|||
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx159590 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx000965 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
abx332445-100ul | Abbexa | 100 ul | 510 EUR |
Keratin 8 Phospho-Ser74 (KRT8 pS74) Antibody |
|||
abx332871-100ul | Abbexa | 100 ul | 560.4 EUR |
Keratin 8 Phospho-Ser432 (KRT8 pS432) Antibody |
|||
20-abx329484 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx329519 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx329581 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx241559 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Protein |
|||
20-abx261119 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Protein |
|||
20-abx261979 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx323513 | Abbexa |
|
|
Keratin 8 Phospho-Ser73 (KRT8 pS73) Antibody |
|||
20-abx325903 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx326337 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx318879 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody |
|||
20-abx213776 | Abbexa |
|
|
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), APC-Cy7 |
|||
4-PAC025Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with APC-Cy7. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), APC-Cy7 |
|||
4-PAC025Ra01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with APC-Cy7. |
|||
Keratin 8 (KRT8) Polyclonal Antibody (Human, Rat), APC-Cy7 |
|||
4-PAC025Ra02-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 8 (KRT8). This antibody is labeled with APC-Cy7. |
|||
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody (HRP) |
|||
20-abx306493 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody (FITC) |
|||
20-abx306494 | Abbexa |
|
|
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody (Biotin) |
|||
20-abx306495 | Abbexa |
|
|
 Human Keratin, type II cytoskeletal 8 (KRT8) |
|||
1-CSB-EP012574HU | Cusabio |
|
|
Description: Recombinant Human Keratin,type II cytoskeletal 8(KRT8),partial expressed in E.coli |
|||
Human Keratin 8 ELISA Kit |
|||
ELA-E2287h | Lifescience Market | 96 Tests | 988.8 EUR |
Human THSD7a ELISA kit |
|||
8-E01A2155 | BlueGene |
|
|
Description: A competitive ELISA for quantitative measurement of Human THSD7a in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC042174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC042174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCAP2174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCAP2174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCH2174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCH2174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCP2174-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCR2174-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), RPE conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC942174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC942174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCA2174-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), APC conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC812174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC812174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCB2174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNCB2174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC882174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC882174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC612174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC612174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC682174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC682174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC432174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC432174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC402174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC402174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC552174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC552174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC802174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC802174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC052174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC052174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC702174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC702174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC472174-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNC472174-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNUB2174-100 | Biotium | 100uL | 316.8 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), Concentration: 0.2mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNUB2174-50 | Biotium | 50uL | 486 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), 1mg/mL |
|||
Cytokeratin 8 (KRT8) (KRT8/2174R) Antibody |
|||
BNUB2174-500 | Biotium | 500uL | 615.6 EUR |
Description: Primary antibody against Cytokeratin 8 (KRT8) (KRT8/2174R), Concentration: 0.2mg/mL |
|||
Keratin 8 Cell ELISA Kit |
|||
abx595344-96tests | Abbexa | 96 tests | 764.4 EUR |
Cytokeratin 8 (KRT8); Clone KRT8/818 (Concentrate) |
|||
RA0177-C.1 | ScyTek Laboratories | 0.1 ml | 150 EUR |
Cytokeratin 8 (KRT8); Clone KRT8/818 (Concentrate) |
|||
RA0177-C.5 | ScyTek Laboratories | 0.5 ml | 360 EUR |
KRT8 Antibody / Cytokeratin 8 |
|||
R20283-0.1ML | NSJ Bioreagents | 100ul | 409 EUR |
KRT8 Antibody / Cytokeratin 8 |
|||
RQ4889 | NSJ Bioreagents | 100 ug | 419 EUR |
KRT8 Antibody / Cytokeratin 8 |
|||
RQ5132 | NSJ Bioreagents | 100ul | 419 EUR |
KRT8 Antibody / Cytokeratin 8 |
|||
V8648-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular ( ring-like, perinuclear ) from ductal ( peripheral-predominant ) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V8648-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular ( ring-like, perinuclear ) from ductal ( peripheral-predominant ) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V8648SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular ( ring-like, perinuclear ) from ductal ( peripheral-predominant ) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V8981-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 8 (also called CK8, Keratin 8 and KRT8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V8981-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: Cytokeratin 8 (also called CK8, Keratin 8 and KRT8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V8981SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 8 (also called CK8, Keratin 8 and KRT8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V9038-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V9038-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V9038IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V9038SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V9039-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V9039-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V9039IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V9039SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2662-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2662-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2662IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2662SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2663-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2663-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2663IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2663SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2664-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2664-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2664IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2664SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V3560-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V3560-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V3560IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V3560SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V3562-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V3562-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V3562IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V3562SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V7042-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V7042-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V7042IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V7042SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. |
|||
KRT8 Antibody / Cytokeratin 8 |
|||
V2169-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. antibody to Cytokeratin 8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against Cytokeratin 8, 18 and 19). Reportedly, Cytokeratin 8 antibody is useful for the differentiation of lobular (“ring-like, perinuclear”) from ductal (“peripheral-predominant”) carcinoma of the breast. |
Human KRT8(Keratin 8) ELISA Kit